SCHEMBL7158010

SCHEMBL7158010

C[C]c1ccc(Br)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2187089 0.83 APP (0.39)
SCHEMBL1666787 0.77 CYP1A1 (0.52)
SCHEMBL1246271 0.73 CYP2A6 (0.57)
SCHEMBL5986844 0.73 CYP2A6 (0.57)
SCHEMBL20015760 0.73 CYP2A6 (0.57)
SCHEMBL3010404 0.71
SCHEMBL2065387 0.71
SCHEMBL9334226 0.71 CYP1A1 (0.64)
SCHEMBL19929691 0.71 CYP2A6 (0.38)
SCHEMBL18508 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10730848-B2 Protective molecules against anthrax toxin THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-08-04 US disclosed
US-20160016930-A1 PROTECTIVE MOLECULES AGAINST ANTHRAX TOXIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-01-21 US disclosed
WO-2014113607-A1 PROTECTIVE MOLECULES AGAINST ANTHRAX TOXIN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-07-24 WO disclosed
EP-1272223-A1 THERAPEUTIC AND DIAGNOSTIC LIGAND SYSTEMS COMPRISING TRANSPORT MOLECULE BINDING PROPERTIES AND MEDICAMENTS CONTAINING THE SAME KTB Tumorforschungsgesellschaft mbH (DE) 2003-01-08 EP disclosed
WO-2001068142-A1 THERAPEUTIC AND DIAGNOSTIC LIGAND SYSTEMS COMPRISING TRANSPORT MOLECULE BINDING PROPERTIES AND MEDICAMENTS CONTAINING THE SAME KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) 2001-09-20 WO disclosed